Globally, the pharmaceutical industry is witnessing a period of rapid transformation. Companies across the board, need to negotiate with the plethora of influences and change-agents, coming their way. As a result, it is becoming increasingly necessary for the medical and commercial teams to innovate their product launches, to address this burgeoning tide.
Digitisation is at the fore front of this change. It has impacted this industry at operational level, patient level, and the product level in varying degrees. This has further impacted the value chain, product pipeline and industry ecosystem.
This whitepaper analyses the effect of Porter's 5 forces in this dynamic environment.
Read this whitepaper to understand how you can leverage the digitalisation wave to your advantage.